The growing complexity of the intestinal polyposis syndromes

American Journal of Medical Genetics, Part A

Volumn 161, Issue 11, 2013, Pages 2777-2787

  Lucci Cordisco, Emanuela ^a   Risio, Mauro ^b   Venesio, Tiziana ^b   Genuardi, Maurizio ^c,d,e  

^a CATHOLIC UNIVERSITY   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ISTITUTO TOSCANO TUMORI   (Italy)

^e Fiorgen Foundation for Pharmacogenomics   (Italy)

Author keywords

AFAP; Cancer risk; FAP; Hereditary mixed polyposis; Juvenile polyposis; MAP; Molecular pathway; Peutz Jeghers syndrome; PTEN tumor hamartoma syndrome; Serrated polyposis

Indexed keywords

ARTICLE; CANCER RISK; CAP INFLAMMATORY POLYPOSIS; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FAMILIAL COLON POLYPOSIS; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOTYPE; HEREDITARY MIXED POLYPOSIS SYNDROME; HISTOPATHOLOGY; HUMAN; INTESTINAL POLYPOSIS SYNDROME; INTESTINE POLYP; JUVENILE POLYPOSIS SYNDROME; MOLECULAR GENETICS; MUTYH ASSOCIATED POLYPOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PEUTZ JEGHERS SYNDROME; PHENOTYPE; POLYMERASE PROOFREADING ASSOCIATED POLYPOSIS; POLYPOSIS; PRIORITY JOURNAL; PTEN HAMARTOMA TUMOR SYNDROME; SERRATED POLYPOSIS; SYNDROME;

AFAP; CANCER RISK; FAP; HEREDITARY MIXED POLYPOSIS; JUVENILE POLYPOSIS; MAP; MOLECULAR PATHWAY; PEUTZ-JEGHERS SYNDROME; PTEN TUMOR HAMARTOMA SYNDROME; SERRATED POLYPOSIS;

ADENOMATOUS POLYPOSIS COLI; GENOTYPE; HUMANS; INTESTINES; MUTATION; PHENOTYPE; SYNDROME;

EID: 84886301764     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36253     Document Type: Article

References (93)

1. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabeu C, Letarte M. 2000. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9:1227-1237.
2. Aretz S, Koch A, Uhlhaas S, Friedl W, Propping P, von Schweinitz D, Pietsch T. 2006. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 47:811-818.
3. Aretz S, Tricarico R, Papi L, Spier I, Pin E, Horpaopan S, Cordisco EL, Pedroni M, Stienen D, Gentile A, et al. 2013. MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. Eur J Hum Genet doi: 10.1038/ejhg.2012.309.
4. Attard TM, Giglio P, Koppula S, Snyder C, Lynch HT. 2007. Brain tumors in individuals with familial adenomatous polyposis: A cancer registry experience and pooled case report analysis. Cancer 109:761-766.
5. Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. 2008. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180-185.
6. Bläker H, Scholten M, Sutter C, Otto HF, Penzel R. 2003. Somatic mutations infamilial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Am J Clin Pathol 120:418-423.
7. Boparai KS, Dekker E, Van Eeden S, Polak MM, Bartelsman JFW, Mathus-Vliegen EM, Keller J, Van Noesel CJM. 2008. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 135:2014-2018.
8. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, Nagengast FM, van Leerdam M, van Noesel CJ, Houben M, Cats A, van Hest LP, Fockens P, Dekker E. 2010. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: A multicentre cohort study. Gut 59:1094-1100.
9. Brosens LA, van Hattem A, Hylind LM, Iacobuzio-Donahue C, Romans KE, Axilbund J, Cruz-Correa M, Tersmette AC, Offerhaus GJ, Giardiello FM. 2007. Risk of colorectal cancer in juvenile polyposis. Gut 56:965-967.
10. Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F, French Cowden Disease Network. 2013. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50:255-263.
11. Bülow S, Christensen IJ, Højen H, Björk J, Elmberg M, Järvinen H, Lepistö A, Nieuwenhuis M, Vasen H. 2012. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 14:947-952.
12. Burt RW, Leppert MF, Slattery ML, Samowitz MS, Spirio LN, Kerber LA, Kuwada SK, Neklason DW, Disario JA, Lyon E, Hughes JP, Chey WY, White RL. 2004. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127:444-451.
13. Calva-Cerqueira D, Chinnathambi S, Pechman B, Bair J, Larsen-Haidle J, Howe JR. 2009. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet 75:79-85.
14. Cao Y, Pieretti M, Marshall J, Khattar NH, Chen B, Kam-Morgan L, Lynch H. 2002. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: Case report with review of the literature. Am J Gastroenterol 97:1822-1827.
15. Carlson GJ, Nivatvongs S, Snover DC. 1984. Colorectal polyps in Cowden's disease (multiple hamartoma syndrome). Am J Surg Pathol 8:763-770.
16. Carvajal-Carmona LG, Howarth KM, Lockett M, Polanco-Echeverry GM, Volikos E, Gorman M, Barclay E, Martin L, Jones AM, Saunders B, Guenther T, Donaldson A, Paterson J, Frayling I, Cheah PYC, Wong YH, Chau YP, Loi C, Lim KH, Lim JF, Koh PK, Eu KW. 2009. Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol 104:3027-3033.
17. Cheah PY, Wong YH, Chau YP, Loi C, Lim KH, Lim JF, Koh PK, Eu KW. 2009. Germline bone morphogenesis protein receptor 1A mutation causes colorectal tumorigenesis in hereditary mixed polyposis syndrome. Am J Gastroenterol 104:3027-3033.
18. Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du Sart D, Young J, Leggett B, Jass J, Macrae F. 2006. Hyperplastic polyposis: Phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131:30-39.
19. Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. 2009. Germline MutY human homologue mutations and colorectal cancer: A multisite case-control study. Gastroenterology 136:1251-1260.
20. Clendenning M, Young JP, Walsh MD, Woodall S, Arnold J, Jenkins M, Win AK, Hopper JL, Sweet K, Gallinger S, Rosty C, Parry S, Buchanan DD. 2013. Germline mutations in the polyposis-associated genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 are not common in individuals with serrated polyposis syndrome. PLoS ONE 8:e66705.
21. Cruz-Correa M, Giardiello FM. 2003. Familial adenomatous polyposis. Gastrointest Endosc 58:885-894.
22. Dahdaleh FS, Carr JC, Calva D, Howe JR. 2012. Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet 81:110-116.
23. Delnatte C, Sanlaville D, Mougenot JF, Vermeesch JR, Houdayer C, Blois MC, Genevieve D, Goulet O, Fryns JP, Jaubert F, Vekemans M, Lyonnet S, Romana S, Eng C, Stoppa-Lyonnet D. 2006. Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet 78:1066-1074.
24. Desai DC, Murday V, Phillips RK, Neale KF, Milla P, Hodgson SV. 1998. A survey of phenotypic features in juvenile polyposis. J Med Genet 35:476-481.
25. Eide TJ. 1986. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 15:173-176.
26. Eng C. 2003. PTEN: One gene, many syndromes. Hum Mutat 22:183-198.
27. Eng CH, Eng C, Burt RW. Cowden syndrome. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. 2010. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press. pp 171-173.
28. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
29. Friedl W, Aretz S. 2005. Familial adenomatous polyposis: Experience from a study of 1164 unrelated German polyposis patients. Hered Cancer Clin Pract 3:95-114.
30. Galiatsatos P, Foulkes WD. 2006. Familial adenomatous polyposis. Am J Gastroenterol 101:385-398.
31. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA. 2004. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852-859.
32. Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR. 1993. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34:1394-1396.
33. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. 2000. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447-1453.
34. Giardiello FM, Burt RW, Jarvinen HJ, Offerhaus GJA. 2010. Familial adenomatous polyposis. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. Lyon, France: IARC Press. pp 147-151.
35. Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH, Witjes MJ, Links TP, van Beek AP. 2008. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 15:2439-2450.
36. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, Kerr MC, Hamilton SR. 1994. Desmoid tumours in familial adenomatous polyposis. Gut 35:377-381.
37. Half E, Bercovich D, Rozen P. 2009. Familial adenomatous polyposis. Orphanet J Rare Dis 4:22.
38. Hazewinkel Y, Reitsma JB, Nagengast FM, Vasen HF, van Os TA, van Leerdam ME, Koornstra JJ, Dekker E. 2013. Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives. Fam Cancer 2013 Apr 17 [Epub ahead of print].
39. Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. 2010. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 139:1927-1933.
40. Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJP, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJA, de Rooij FWM, Wilson JHP, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RKS, Spigelman AD, Houlston RS. 2006. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12:3209-3215.
41. Howe JR, Mitros FA, Summers RW. 1998. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 5:751-756.
42. Howe JR, Haidle JL, Lal G, Bair J, Song C, Pechman B, Chinnathambi S, Lynch HT. 2007. ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis. Clin Genet 71:91-92.
43. Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado PR, Davis H, Kaur K, Heinimann K, Howarth K, East J, Taylor J, Thomas H, Tomlinson I. 2012. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 44:699-703.
44. Jass JR. 1990. Pathology of polyposis syndromes with special reference to juvenile polyposis. Utsonomiya J, Lynch H, editors. Hereditary colorectal cancer. Tokyo: Springer-Verlag. pp 343-350.
45. Jass JR. 2008. Colorectal polyposis: From phenotype to diagnosis. Pathol Res Pract 204:431-447.
46. Jass JR, Williams CB, Bussey HJR, Morson BC. 1988. Juvenile polyposis-A precancerous condition. Histopathology 13:619-630.
47. Jass JR, Whitehall VL, Young J, Leggett BA. 2002. Emerging concepts in colorectal neoplasia. Gastroenterology 123:862-876.
48. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR, Cheadle JP. 2002. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961-2967.
49. Kalady MF, Jarrar A, Leach B, LaGuardia L, O'Malley M, Eng C, Church JM. 2011. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 54:164-170.
50. Lage P, Cravo M, Sousa R, Chaves P, Salazar M, Fonseca R, Claro I, Suspiro A, Rodrigues P, Raposo H, Fidalgo P, Nobre-Leitão C. 2004. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: A contribution for future guidelines based on a clinical study. Am J Gastroenterol 99:1779-1784.
51. Lanza G, Messerini L, Gafà R, Risio M. 2011. Colorectal tumors: The histology report. Dig Liver Dis 43:S344-S355.
52. Latchford AR, Neale K, Phillips RK, Clark SK. 2012. Juvenile polyposis syndrome: A study of genotype, phenotype, and long-term outcome. Dis Colon Rectum 55:1038-1043.
53. Ledwidge SF, Moorghen M, Longman RJ, Thomas MG. 2007. Adult transmural intestinal ganglioneuromatosis is not always associated with multiple endocrine neoplasia or neurofibromatosis: A case report. J Clin Pathol 60:222-223.
54. Lipton L, Tomlinson I. 2004. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2:633-638.
55. Lipton L, Halford SE, Johnson V, Novelli MR, Jones A, Cummings C, Barclay E, Sieber O, Sadat A, Bisgaard ML, Hodgson SV, Aaltonen LA, Thomas HJ, Tomlinson IP. 2003. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595-7599.
56. Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. 2009. Clinical implications of the colorectal cancer risk associated with MUTYH mutations. J Clin Oncol 27:3975-3980.
57. Luo F, Poulogiannis G, Ye H, Hamoudi R, Arends MJ. 2011. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis. Oncol Rep 26:125-133.
58. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N Engl J Med 348:919-932.
59. Matsumoto T, Iida M, Kobori Y, Mizuno M, Nakamura S, Hizawa K, Yao T. 2002. Serrated adenoma in familial adenomatous polyposis: Relation to germline APC gene mutation. Gut 50:402-404.
60. McGarrity TJ, Kulin HE, Zaino RJ. 2000. Peutz-Jeghers syndrome. Am J Gastroenterol 95:596-604.
61. National Comprehensive Cancer Network, 2013. NCCN Practice Guidelines for Colorectal Cancer Screening. Version 2.2013. http://www.nccn.org.
62. Ngeow J, Heald B, Rybicki LA, Orloff MS, Chen JL, Liu X, Yerian L, Willis J, Lehtonen H, Lehtonen R, Mester JL, Moline J, Burke CA, Church J, Aaltonen LA, Eng C. 2013. Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps. Gastroenterology 144:1402-1409.
63. Nieuwenhuis MH, Vogt S, Jones N, Nielsen M, Hes FJ, Sampson JR, Aretz S, Vasen HF. 2012. Evidence, for accelerated colorectal adenoma-carcinoma progression in MUTYH-associated polyposis? Gut 61:734-738.
64. Offerhaus GJA, Howe JR. 2010. Juvenile polyposis. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. Lyon, France: IARC Press. pp 166-167.
65. O'Malley M, LaGuardia L, Kalady MF, Parambil J, Heald B, Eng C, Church J, Burke CA. 2012. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum 55:886-892.
66. Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, Sherborne A, Chubb D, Carvajal-Carmona LG, Ma Y, Kaur K, Dobbins S, Barclay E, Gorman M, Martin L, Kovac MB, Humphray S, CORGI Consortium, WGS500 Consortium, Lucassen A, Holmes CC, Bentley D, Donnelly P, Taylor J, Petridis C, Roylance R, Sawyer EJ, Kerr DJ, Clark S, Grimes J, Kearsey SE, Thomas HJ, McVean G, Houlston RS, Tomlinson I, 2013. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45:136-144.
67. Pilarski R, Eng C. 2004. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-326.
68. Pilarski R., 2009. Cowden syndrome: A critical review of the clinical literature. J Genet Couns 18:13-27.
69. Ponz de Leon M, Di Gregorio C, Giunti L, Roncucci L, Pedroni M, Tinca AC, Crucianelli F, Tricarico R, Genuardi M. 2013. Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. Dig Liver Dis 45:75-78.
70. Pritchard CC, Smith C, Salipante SJ, Lee MK, Thornton AM, Nord AS, Gulden C, Kupfer SS, Swisher EM, Bennett RL, Novetsky AP, Jarvik GP, Olopade OI, Goodfellow PJ, King MC, Tait JF, Walsh T. 2012. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 14:357-366.
71. Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Bertario L, Genuardi M, Lucci-Cordisco E, Tibiletti MG, Di Gregorio C, Andriulli A, Ponz de Leon M, AIFEG. 2013. Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: Results of an Italian multicenter study. Dig Liver Dis 45:606-611.
72. Riegert-Johnson DL, Gleeson FC, Roberts M, Tholen K, Youngborg L, Bullock M, Boardman LA. 2010. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 8:6.
73. Rubio CA, Stemme S, Jaramillo E, Lindblom A. 2006. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 38:266-270.
74. Snover DC. 2005. Serrated polyps of the large intestine. Semin Diagn Pathol 22:301-308.
75. Snover DC, Ahnen DJ, Burt RW, Odze RD. 2010. Serrated polyps of the colon and rectum and serrated polyposis. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumours of the digestive system. Lyon, France: IARC Press. pp 160-165.
76. Steinhagen E, Guillem JG, Chang G, Salo-Mullen EE, Shia J, Fish S, Stadler ZK, Markowitz AJ. 2012. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer 11:304-308.
77. Sweet K, Willis J, Zhou XP, Gallione C, Sawada T, Alhopuro P, Khoo SK, Patocs A, Martin C, Bridgeman S, Heinz J, Pilarski R, Lehtonen R, Prior TW, Frebourg T, Teh BT, Marchuk DA, Aaltonen LA, Eng C. 2005. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294:2465-2473.
78. Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. 2011. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88:42-56.
79. Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. 2012. Lifetime cancer risks in individuals with germline PTEN mutations Clin Cancer Res 18:400-407.
80. Tanskanen T, Gylfe AE, Katainen R, Taipale M, Renkonen-Sinisalo L, Mecklin JP, Järvinen H, Tuupanen S, Kilpivaara O, Vahteristo P, Aaltonen LA. 2013. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Scand J Gastroenterol 48:672-678.
81. Tomlinson I, Jaeger E, Leedham S, Thomas H. 2013. Reply to "The classification of intestinal polyposis". Nat Genet 45:2-3.
82. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, Snover DC. 2008. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32:21.
83. Trufant JW, Greene L, Cook DL, McKinnon W, Greenblatt M, Bosenberg MW. 2012. Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: A case report and literature review. Hum Pathol 43:601-604.
84. van der Linde K, Vasen HF, van Vliet AC. 1998. Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases. Eur J Gastroenterol Hepatol 10:777-781.
85. van Hattem WA, Brosens LA, de Leng WW, Morsink FH, Lens S, Carvalho R, Giardiello FM, Offerhaus GJ. 2008. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut 57:623-627.
86. van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME. 2010. High cancer risk in Peutz-Jeghers syndrome: A systematic review and surveillance recommendations. Am J Gastroenterol 105:1258-1264.
87. van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. 2008. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res 14:139-142.
88. Vasen HF, Bülow S, Myrhøj T, Mathus-Vliegen L, Griffioen G, Buskens E, Taal BG, Nagengast F, Slors JF, de Ruiter P. 1997. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 40:716-719.
89. Venesio T, Balsamo A, Errichiello E, Ranzani GN, Risio M. 2013. Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes. Mod Pathol Apr 19. doi: 10.1038/modpathol.2013.66
90. Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufman A, Steinke V, Vasen HF, Propping P, Sampson JR, Hes FJ, Aretz S. 2009. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 137:1976-1985.
91. Whitelaw SC, Murday VA, Tomlinson IPM, Thomas HJW, Cottrell S, Ginsberg A, Bukofzer S, Hodgson SV, Skudowitz RB, Jass JR, Talbot IC, Northover JMA, Bodmer WF, Solomon E. 1997. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112:327-334.
92. Williams GT, Bussey HJR, Morson BC. 1985. Inflammatory "cap" polyps of the large intestine. Br J Surg 72: 133 (Abst).
93. Young J, Jass JR. 2006. The case for a genetic predisposition to serrated neoplasia in the colorectum: Hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15:1778-1784.